Literature DB >> 4040006

The effect of topically applied prostaglandin inhibitors on the laser-induced disruption of the blood aqueous barrier.

W Schrems, H P van Dorp, S Mager, G K Krieglstein.   

Abstract

The therapeutic effect of topically applied prostaglandin inhibitors on the laser-induced disruption of the blood-aqueous barrier was investigated in six series of five rabbits each. One series was not coagulated and served as baseline, and in a reference group laser coagulation was performed without pretreatment with a prostaglandin inhibitor. In four series the iris laser coagulation of the left eyes was preceded by topical application of a prostaglandin inhibitor. The right eyes served as controls for the contralateral effect on the blood aqueous barrier. After laser coagulation the intraocular pressure was monitored at 10-min intervals, and the anterior chamber was tapped for analysis of the protein concentration and the lactate dehydrogenase activity. Pretreatment with dexamethasone eyedrops and indomethacin eyedrops markedly blocked the laser-induced disruption of the blood-aqueous barrier. The level of protein concentration in the aqueous humor after laser coagulation was much less after pretreatment with dexamethasone or indomethacin eyedrops. The effect was significant, both for the laser-treated eyes and for the noncoagulated fellow eyes (p less than 0.025). The subconjunctival pretreatment with dexamethasone 1 or 24 h before laser coagulation had no significant effect with respect to the protection of the blood aqueous barrier.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040006     DOI: 10.1007/bf00159264

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  10 in total

1.  Comparison of ocular prostaglandin synthesis inhibitors.

Authors:  S M Podos; B Becker
Journal:  Invest Ophthalmol       Date:  1976-10

2.  Inhibition of the prostaglandin synthetase systems in ocular tissues by indomethacin.

Authors:  P Bhattacherjee; K E Eakins
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

3.  Studies on the blood-aqueous barrier after argon laser photocoagulation of the iris.

Authors:  D R Sanders; B Joondeph; R Hutchins; D Schwartz; T Yeh; G A Peyman
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

4.  Prostaglandins and ocular inflammation.

Authors:  D W Hall; I L Bonta
Journal:  Doc Ophthalmol       Date:  1977-12-30       Impact factor: 2.379

5.  Mechanism of steroid action in ocular inflammation: Inhibition of prostaglandin production.

Authors:  N Floman; U Zor
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-01       Impact factor: 4.799

6.  The release of prostaglandins in human aqueous humour following intraocular surgery. Effect of indomethacin.

Authors:  M Kremer; G Baikoff; B Charbonnel
Journal:  Prostaglandins       Date:  1982-05

7.  Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease.

Authors:  S M Podos
Journal:  Trans Am Ophthalmol Soc       Date:  1976

8.  The effect of prostaglandin inhibitors on the laser-induced disruption of blood aqueous barrier in the rabbit.

Authors:  W Schrems; H P van Dorp; S Mager; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

9.  Breakdown and reestablishment of blood-aqueous barrier with implant surgery.

Authors:  D R Sanders; M C Kraff; H L Lieberman; G A Peyman; S Tarabishy
Journal:  Arch Ophthalmol       Date:  1982-04

10.  The effect of indomethacin on the anterior segment of the eye after paracentesis.

Authors:  J A Oosterhuis; N J van Haeringen; E Glasius; J L van Delft; M Swart-van den Berg
Journal:  Doc Ophthalmol       Date:  1981-03-20       Impact factor: 2.379

  10 in total
  1 in total

1.  The effect of YAG laser iridotomy on the blood aqueous barrier in the rabbit.

Authors:  W Schrems; H P van Dorp; M Wendel; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.